Label: CYCLOPHENE kit

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated July 25, 2016

If you are a consumer or patient please visit this version.

  • Instructions for PharmacistPage 1Page 2

    NDC 70332-102-01

    For Prescription Compounding Only

    Rx only


    RapidPaq™
    CYCLOPHENE™
    (5% cyclobenzaprine hydrochloride topical cream kit)

    RapidPaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP).

    Description:
    This kit contains active and inactive materials to prepare approximately 111.2 grams of Cyclobenzaprine Hydrochloride topical cream. This kit may only be used for prescription compounding by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.

    Active Ingredients:
    - 5.6 g Cyclobenzaprine Hydrochloride [equivalent to 4.9 g Cyclobenzaprine]

    Inactive Ingredients:
    - 100 g RapidPaq Cream Base (D. l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and)ethylhexylglycerin,
    Tocopheryl Acetate, Aloe Barbadensis, Disodium EDTA)
    - 5.6 Ethoxy Diglycol
    - Spatula
    - Instructions

    Pharmacist Instructions for Preparation

    1 Remove and Inspect the Contents of the Kit

    Ensure that all components are present. Ensure that the safety seals are present on the Cyclobenzaprine Hydrochloride, ethoxy diglycol and RapidPaq Cream Base. If components are missing or the safety seals are not intact do not use the kit.

    2 Prepare for Mixing

    Wear gloves and eye protection during mixing operations. Remove the cap and seal from the RapidPaq Cream Base. Break the perforated seal and remove the cap from the Cyclobenzaprine Hydrochloride and ethoxy diglycol.

    3 Dissolve the Cyclobenzaprine Hydrochloride

    Using a spatula make a well in the center of the RapidPaq Cream Base. Transfer approximately half of the ethoxy diglycol to the Cyclobenzaprine Hydrochloride bottle. Cap the Cyclobenzaprine Hydrochloride bottle and shake to ensure that all residue Cyclobenzaprine Hydrochloride has been dissolved. Pour the contents into the RapidPaq Cream Base. Repeat this step with the remaining ethoxy diglycol.

    4 Complete the Mixing Process

    Using the spatula, mix the RapidPaq Base jar that now contains the ethoxy diglycol and cyclobenazprine hydrochloride ingredients thoroughly for about 2 minutes or until fully dissolved.

    5 Relabel the Resulting Cream

    Label the resulting topical cream as required for prescription products. Ensure that the original RapidPaq Cream Base label is removed or obscured, since the original label is no longer accurate once the cream is prepared.

    Discard the spatula.

    Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the topical cream between 15-30°C (59-86°F). The final cream is stable for up to eight weeks.

    U.S. Patents Pending

    Repackaged and Distributed by:
    California Pharmaceuticals, LLC
    768 Calle Plano
    Camarillo, CA 93012

    California
    PHARMACEUTICALS LLC

    CS107-A1 rev 3

    Cyclophene instructions

    Cyclophene instructions

  • Cyclobenzaprine Hydrochloride product label

    Do not use if saety seal is broken

    Cyclobenzaprine Hydrochloride

    1-propanamine, 3-(5H-dibenzo[a,d]cycloheptenn-5-ylidene)-N,N-dimethyl-, hydrochloride

    RxOnly

    CAS # 6202-23-9

    Net contents 5.6 g

    Repackaged by:

    California Pharmaceuticals, LLC

    Camarillo, CA 93012

    California

    PHARMACEUTICALS LLC

    CS104-A1 rev 1

    Cyclobenzaprine label

  • RapidPaq Cream Base product label

    Do not use if seal is broken

    RapidPaq™ Cream base

    Net contents: 100 g

    Ingredients: (D.l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and)ethylhexylglycerin, Tocopheryl Acetate,

    Aloe barbadensis, Disodium EDTA.)

    RX Only

    Manufactured for California Pharmaceyticals, LLC, Camarillo, CA 93012

    RapidPaq Cream Base

  • CYCLOPHENE Kit product label

    NDC 70332-102-01

    Rx only

    RapidPaq™

    Kit for Topical Cream

    CYCLOPHENE™

    (5% cyclobenzaprine hydrochloride topical cream kit)

    Muscle relaxant

    Store at room temperature,

    15-30°C (59-86°F)

    Description:

    This kit contains active and inactive materials to prepare approximately 111.2 grams of Cyclobenzaprine Hydrochloride topical cream. This kit may only be used for prescription compounding by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.

    Active ingredient

    - 5.6 g Cyclobenzaprine Hydrochloride USP [equivalent to 4.9 g Cyclobenzaprine]

    Inactive Ingredients:

       - 100 g RapidPaq Cream Base(D.l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and) ethylhexylglycerin,

                                                    Tocopheryl Acetate, Aloe Barbadensis, Disodium EDTA)

       - 5.6 g Ethoxy Diglycol

       - Spatula

       - Instructions

    U.S. Patents Pending

    Do not use if safety seal is broken

    California

    PHARMACEUTICALS LLC

    Repacked and Distributed By;

    Caifornis Pharmaceuticals, LLC

    768 Calle Plano

    Camarillo, CA 93012

    CS 108-A1 rev 1

    Cyclophene Kit

  • INGREDIENTS AND APPEARANCE
    CYCLOPHENE 
    cyclophene kit
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70332-102
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70332-102-011 in 1 KIT01/01/2016
    Quantity of Parts
    Part #Package QuantityTotal Product Quantity
    Part 11 BOTTLE 5.6 g
    Part 21 BOTTLE 5.6 g
    Part 31 JAR 100 g
    Part 1 of 3
    ETHOXY DIGLYCOL 
    diethylene glycol monoethyl ether liquid
    Product Information
    Route of AdministrationTOPICAL
    Inactive Ingredients
    Ingredient NameStrength
    DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    15.6 g in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2016
    Part 2 of 3
    CYCLOBENZAPRINE HYDROCHLORIDE 
    cyclobenzaprine hydrochloride powder
    Product Information
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CYCLOBENZAPRINE HYDROCHLORIDE (UNII: 0VE05JYS2P) (CYCLOBENZAPRINE - UNII:69O5WQQ5TI) CYCLOBENZAPRINE HYDROCHLORIDE5.6 g  in 5.6 g
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    15.6 g in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2016
    Part 3 of 3
    RAPIDPAQ CREAM BASE 
    rapidpaq cream base cream
    Product Information
    Route of AdministrationTOPICAL
    Inactive Ingredients
    Ingredient NameStrength
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    WATER (UNII: 059QF0KO0R)  
    POLYSORBATE 60 (UNII: CAL22UVI4M)  
    SORBITOL (UNII: 506T60A25R)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1100 g in 1 JAR; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2016
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/01/2016
    Labeler - California Pharmaceuticals LLC (021420944)
    Registrant - California Pharmaceuticals LLC (021420944)
    Establishment
    NameAddressID/FEIBusiness Operations
    California Pharmaceuticals LLC021420944manufacture(70332-102) , repack(70332-102)